Jan 16
Prepare and Send to Global Site: Complete the intake process to communicate the adverse event information to the site for processing. This can involve data entry to an online form, uploading of source documents, and any required translations. Prepared cases can then be sent to case regional or global processing sites as per the structural setup of the company.
In 2020:
70% of respondents were applying at least some level of automation.
30% of respondents reported no automation of this ICSR process step.
In 2021:
67% of respondents were applying at least some automation.
33% of respondents reported no automation of this ICSR process step.
Related Blog Posts
Science is Moving—Clinical Trials Must Catch Up
Clinical research has never been more capable of reaching new frontiers. The science is here. The technology is here. But the approach to trial design and execution hasn’t kept pace. The clinical research ecosystem proceeds cautiously for good reasons—patient safety chief among them. But too often, we’re held back by fixed mindsets and outdated processes.…
The Impact of ICH E6(R3) – Sponsor and CRO Perspectives
In ACRO and TransCelerate BioPharma’s latest collaboration, Cris McDavid (Senior Director, Global Clinical Operations, Parexel) and Tashan Mistree (Senior Director, Business Operations, Office of Chief Medical Officer, GSK) join this week’s episode to discuss the impact of ICH E6(R3) from their different vantage points in the clinical research industry. Listen to the podcast by Cris McDavid and Tashan Mistree…
Unifying Industry to Better Understand GCP Guidance
In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate…